Park National Corp OH Raises Stake in Danaher Corporation $DHR

Key Points

• Park National Corp OH increased its stake in Danaher Corporation by 2.9%, owning 86,201 shares valued at approximately $17 million as of the end of the second quarter.
• Danaher reported earnings of **$1.80 per share** for its latest quarter, exceeding estimates by $0.16, and showed a year-over-year revenue growth of 3.4%.
• The company has announced a quarterly dividend of $0.32 per share, with an annualized yield of 0.7% and a payout ratio of 27.23%.

Park National Corp OH lifted its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 2.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 86,201 shares of the conglomerate's stock after buying an additional 2,432 shares during the quarter. Park National Corp OH's holdings in Danaher were worth $17,028,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. GHP Investment Advisors Inc. grew its holdings in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after buying an additional 99 shares in the last quarter. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the fourth quarter worth about $27,000. Sierra Ocean LLC grew its holdings in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher in the first quarter valued at approximately $31,000. Finally, Dunhill Financial LLC grew its holdings in Danaher by 68.4% in the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 67 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the business's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 11.10% of the company's stock.

Danaher Price Performance

DHR opened at $190.07 on Friday. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The company has a 50 day moving average of $201.21 and a two-hundred day moving average of $198.90. The company has a market cap of $136.10 billion, a P/E ratio of 40.44, a P/E/G ratio of 2.72 and a beta of 0.75.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the previous year, the firm earned $1.72 earnings per share. Danaher's revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's payout ratio is presently 27.23%.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DHR. Guggenheim restated a "buy" rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. UBS Group lowered their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price for the company in a report on Friday, July 11th. Barclays restated an "overweight" rating and issued a $225.00 target price (up from $215.00) on shares of Danaher in a report on Tuesday, June 24th. Finally, Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $246.35.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.